NCT06823830View on ClinicalTrials.gov

Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Jinfeng Pill

Jinfeng pills were compared with Diane-35 group and Jinfeng pills combined with Diane-35 group were compared with Diane-35 alone.

Trial Locations (1)

1000730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER